Ladenburg Thalmann Financial Services’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$0 Hold
150
﹤0.01% 5631
2019
Q3
$1K Hold
150
﹤0.01% 5218
2019
Q2
$1K Hold
150
﹤0.01% 5220
2019
Q1
$4K Hold
150
﹤0.01% 4786
2018
Q4
$3K Hold
150
﹤0.01% 4832
2018
Q3
$8K Hold
150
﹤0.01% 4419
2018
Q2
$9K Hold
150
﹤0.01% 4332
2018
Q1
$9K Hold
150
﹤0.01% 4332
2017
Q4
$19K Hold
150
﹤0.01% 3841
2017
Q3
$21K Hold
150
﹤0.01% 3666
2017
Q2
$21K Sell
150
-163
-52% -$25.2K ﹤0.01% 3601
2017
Q1
$58K Hold
313
﹤0.01% 2812
2016
Q4
$25K Buy
313
+163
+109% +$12.9K ﹤0.01% 3353
2016
Q3
$11K Hold
150
﹤0.01% 3779
2016
Q2
$13K Sell
150
-4
-3% -$366 ﹤0.01% 3632
2016
Q1
$14K Hold
154
﹤0.01% 3520
2015
Q4
$31K Hold
154
﹤0.01% 2926
2015
Q3
$23K Buy
154
+145
+1,611% +$106K ﹤0.01% 3030
2015
Q2
$8K Hold
9
﹤0.01% 3843
2015
Q1
$6K Hold
9
﹤0.01% 3924
2014
Q4
$7K Hold
9
﹤0.01% 3603
2014
Q3
$3K Hold
9
﹤0.01% 3607
2014
Q2
$2K Buy
9
+4
+80% +$858 ﹤0.01% 3680
2014
Q1
$1K Hold
5
﹤0.01% 3674
2013
Q4
$1K Buy
+5
New +$1.19K ﹤0.01% 3660

Other funds holding TTPH

Ladenburg Thalmann Financial Services's TTPH Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Tetraphase Pharmaceuticals, Inc. (TTPH) position steady in Q4 2019 at 150 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5631.

Ladenburg Thalmann Financial Services first reported a position in TTPH in Q4 2013 and has held it in 25 quarters since. The position peaked at $58K in Q1 2017. 23 funds tracked by Wall St. Rank hold TTPH as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 150 shares of Tetraphase Pharmaceuticals, Inc. worth $0 as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its Tetraphase Pharmaceuticals, Inc. share count unchanged in Q4 2019.
  • Tetraphase Pharmaceuticals, Inc. made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5631 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2013 and has held it in 25 quarters since.
  • Ladenburg Thalmann Financial Services's Tetraphase Pharmaceuticals, Inc. position peaked at $58K in Q1 2017.
  • 23 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.